AbCellera receives $175.6 mn from Canada for coronavirus research
By Akshay Kedari  Date: 2020-05-04

AbCellera receives $175.6 mn from Canada for coronavirus research

Healthcare companies are racing against time to develop a vaccine for COVID-19 which has killed thousands of people across the world. Given the dire situation, healthcare companies are seeking financial support from governments and philanthropists for developing novel COVID-19 treatments and vaccines.

A similar incident comes into light when AbCellera Biologics Inc., the Canada-based biotechnology firm, has received a financial commitment of up to USD 175.6 from the Canadian Government for accelerating efforts to develop novel therapies to treat COVID-19. The company is also expected to use this funding to develop cutting-edge technologies and manufacturing facilities for antibody treatment against future pandemic threats.

Sources cite that the company is using its antibody discovery platform to study blood samples of patients who have recovered from coronavirus disease. In collaboration with VRC (Vaccine Research Centre) at the National Institute of Allergy and Infection Diseases, the company has identified more than 500 unique human anti-SARS-CoV-2 antibodies. These antibodies may also be used to develop novel diagnostic tests to aid the medical community in monitoring COVID-19 spread.

Speaking on which, Navdeep Bains, Minister of Innovation, Science and Industry said that the Government of Canada is mobilizing its resources to confront COVID-19 and aiding the businesses and researchers that are working diligently to create novel therapies to tackle this pandemic. The funding would support AbCellera Biologicsto rapidly discover new solutions for COVID-19 while ensuring the nation’s long-term preparedness for future healthcare threats, Bains added.

Carl Hansen, Ph.D., CEO at AbCellera stated that the company is proud to have the support from the Canadian Government to rapidly find solutions to the ongoing pandemic.

As per sources, the company has received a financial commitment for funding under ISED’s (Innovation, Science and Economic Development) Strategic Innovation fund. With this initiative, the Government of Canada is aiming to support companies that are working on developing COVID-19 vaccines and critical medical supplies.

Source Credit - https://www.abcellera.com/news/2020-05-03

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Medtronic to acquire Companion Medical to expand diabetes business
Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical. The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, wh...

RADCOM introduces automated assurance solution for 5G technology
RADCOM introduces automated assurance solution for 5G technology
By Akshay Kedari

5G technology has been in the headlines for quite a while. Next-generation technology has the potential to transform almost every sector across the world. However, as 5G becomes reality, it has become imperative for service providers to prevent degra...

Sprout to expand wellness solutions lineup by acquiring Vivametrica
Sprout to expand wellness solutions lineup by acquiring Vivametrica
By Akshay Kedari

Sprout, a Canadian company that focuses on delivering innovative solutions for workplace wellbeing, has recently announced the acquisition of predictive health data analytics firm, Vivametrica. According to reliable sources, Sprout plans to enhance t...

Uber halts decision to shift APAC headquarters from Singapore
Uber halts decision to shift APAC headquarters from Singapore
By Akshay Kedari

Uber Technologies Inc., the American ride-hailing giant, has reportedly halted the company’s decision to relocate its Asia Pacific headquarters from Singapore to Hong Kong until December 2022. Sources cite that the company’s decision was...

PCI Pharma extends global clinical supply-chain services in Europe
PCI Pharma extends global clinical supply-chain services in Europe
By Akshay Kedari

U.S. based biopharmaceutical and pharma outsourcing services company, PCI Pharma services has reportedly announced that it reached a noteworthy milestone through the development of COE (Clinical Center of Excellence) in Berlin. According to credible...